Clinical Trial Risk Scoring for Adaptive Monitoring Decisions
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The high cost and resource-intensive nature of clinical trial monitoring, particularly Source Data Verification (SDV), is exacerbated by the increasing complexity of decentralized data sources, necessitating a more efficient and intelligent method to identify and manage risks in clinical trials.
Innovation Solution
A system utilizing a machine learning model that defines risk categories, calculates risk profiles, and predicts an overall risk score for clinical trials, enabling proactive risk-based monitoring (RBM) through self-learning and adaptive decision-making.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If 100% Source Data Verification (SDV) is performed by clinical research associates, then data integrity and accuracy are ensured, but monitoring costs and resource consumption increase significantly
Solution Approach 1:
The patent replaces the mechanical system of manual SDV by clinical research associates with an automated electronic system that uses machine learning models and algorithms to verify source data. The system automatically collects data from electronic health records, compares it with trial data, and identifies discrepancies, eliminating the need for extensive manual verification while maintaining data integrity.
Solution Approach 2:
The system enables self-service monitoring by automatically performing data verification tasks without requiring continuous human intervention. The machine learning models autonomously analyze data patterns, identify risks, and generate monitoring reports, allowing the system to serve itself in the data verification process while reducing dependency on human resources.
2Productivity
If centralized monitoring is implemented to oversee clinical trials, then monitoring efficiency is improved, but the complexity of managing multiple data sources increases
Solution Approach 1:
The patent implements a universal monitoring system that can handle multiple types of data sources (electronic health records, trial databases, regulatory systems) through a single integrated platform. The system performs multiple functions including data collection, validation, risk assessment, and reporting within one system architecture, reducing the complexity that would arise from managing separate systems for each function.
Solution Approach 2:
The system introduces an intermediary layer of intelligence using machine learning models that mediate between diverse data sources and the monitoring process. These models standardize data from different sources, translate various data formats into a common structure, and provide a unified interface for monitoring, thereby simplifying the management of multiple data sources.
3Ease of operation
If traditional site-focused monitoring is used, then all sites receive uniform monitoring attention, but resources are wasted on low-risk sites while high-risk sites may be understaffed
Solution Approach 1:
The patent applies local quality by tailoring the monitoring intensity and resources to the specific risk profile of each clinical trial site. The system calculates risk scores for individual sites based on multiple factors and dynamically adjusts monitoring frequency and depth accordingly, allocating more resources to high-risk sites and fewer resources to low-risk sites, thereby optimizing resource allocation efficiency.
Solution Approach 2:
The system implements dynamic monitoring where the monitoring plan is not static but continuously adapts based on real-time risk assessments. As risk factors change at different sites, the system automatically adjusts monitoring strategies, transitioning from uniform static monitoring to dynamic risk-proportionate monitoring that responds to changing conditions.
Data Source
AI summary
According to an embodiment, disclosed is a system comprising a processor configured to define, one or more risk categories for monitoring a risk associated with a clinical trial, wherein the risk categories comprise one or more risk elements; calculate, a first risk profile data of the risk categories based on a risk factor and a weighting assigned to the risk elements; generate, a machine learning (ML) model; train, the ML model; receive, a second risk profile data; analyse, the second risk profile data to identify a pattern based on the first risk profile data using a database; predict, an overall risk score; recommend, one or more of a type of monitoring, a level of monitoring, and the overall risk score; and wherein the ML model comprises a feed-back layer to enable continuous learning and improve the prediction of the overall risk score and monitoring decisions of the clinical trial.